Evidence map›Paper›PMID 36878967›Full record

ArticleMolecular psychiatry2023

Human brain organoid model of maternal immune activation identifies radial glia cells as selectively vulnerable.

Kseniia Sarieva, Theresa Kagermeier, Shokoufeh Khakipoor, Ezgi Atay, Zeynep Yentür, Katharina Becker, Simone Mayer

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Genes · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kseniia SarievaHertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Theresa KagermeierHertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-7557-8523
Shokoufeh KhakipoorHertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Ezgi AtayHertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Zeynep YentürHertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-4832-9927
Katharina BeckerHertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Simone MayerHertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. si.mayer@uni-tuebingen.de.ORCID 0000-0002-6381-2474
Hertie Institute for Clinical Brain Research · DEHeidelberg Academy of Sciences and Humanities · DE

Funding

Brain and Behavior Research Foundation (Brain & Behavior Research Foundation) 27026Daimler und Benz Stiftung (Daimler and Benz Foundation) 32-06/20Gemeinnützige Hertie-Stiftung (Hertie Foundation) N/AHeidelberger Akademie der Wissenschaften (Heidelberg Academy of Sciences and Humanities) WIN KollegHeidelberger Akademie der Wissenschaften (Heidelberg Academy of Sciences and Humanities) WIN-KollegMinisterium für Wissenschaft, Forschung und Kunst Baden-Württemberg (Ministry of Science, Research and Art Baden-Württemberg) Landesgraduiertenförderung
6 · The paper itself

Abstract

Maternal immune activation (MIA) during critical windows of gestation is correlated with long-term neurodevelopmental deficits in the offspring, including increased risk for autism spectrum disorder (ASD) in humans. Interleukin 6 (IL-6) derived from the gestational parent is one of the major molecular mediators by which MIA alters the developing brain. In this study, we establish a human three-dimensional (3D) in vitro model of MIA by treating induced pluripotent stem cell-derived dorsal forebrain organoids with a constitutively active form of IL-6, Hyper-IL-6. We validate our model by showing that dorsal forebrain organoids express the molecular machinery necessary for responding to Hyper-IL-6 and activate STAT signaling upon Hyper-IL-6 treatment. RNA sequencing analysis reveals the upregulation of major histocompatibility complex class I (MHCI) genes in response to Hyper-IL-6 exposure, which have been implicated with ASD. We find a small increase in the proportion of radial glia cells after Hyper-IL-6 treatment through immunohistochemistry and single-cell RNA-sequencing. We further show that radial glia cells are the cell type with the highest number of differentially expressed genes, and Hyper-IL-6 treatment leads to the downregulation of genes related to protein translation in line with a mouse model of MIA. Additionally, we identify differentially expressed genes not found in mouse models of MIA, which might drive species-specific responses to MIA. Finally, we show abnormal cortical layering as a long-term consequence of Hyper-IL-6 treatment. In summary, we establish a human 3D model of MIA, which can be used to study the cellular and molecular mechanisms underlying the increased risk for developing disorders such as ASD.

Indexed as

Autism Spectrum DisorderBrainInduced Pluripotent Stem CellsInterleukin-6OrganoidsAnimalsEpendymoglial CellsFemaleHumansMiceNeurogliaPregnancyPrenatal Exposure Delayed EffectsProsencephalonSignal TransductionInterleukin-6

Identifiers

PMID36878967
PMCPMC9986664
OpenAlexW4323314557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.